Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Francois van Loggerenberg

Datos Biográficos

ID7728636
NOMBREFrancois van Loggerenberg
NOMBRESFrancois
APELLIDOvan Loggerenberg
FIRMAVAN LOGGERENBERG F
AFILIACIONESCentre for the AIDS Programme of Research in South Africa
ORCID0000-0001-5317-7983
VERIFICADOSí
TOTAL DE OBRAS7
TOTAL DE CITAS0
TOTAL COMO AUTOR7
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2013
AÑO MÁS RECIENTE DE PUBLICACIÓN2015
ÍNDICE H0
  • Risk Factors for HIV Acquisition in High Risk Women in a Generalised Epidemic Setting

    Open Access•Nivashnee Naicker, Ayesha B M Kharsany et al.•ARTICLE•AIDS and Behavior•2015

  • Trial participation disclosure and gel use behavior in the Caprisa 004 tenofovir gel trial

    Stacey Succop, Stacey M Succop et al.•ARTICLE•AIDS Care•2014

    Disclosure, or open communication, by female microbicide trial participants of their trial participation and use of an investigational HIV prevention drug to a sexual partner may affect participants' trial product usage behavior and contribute to poor adherence. With mixed results from recent microbicide clinical trials being linked to differing participant adherence, insights into the communication dynamics between trial participants and their s…

  • Impact of Antiretroviral Therapy on Health-Related Quality of Life among South African Women in the Caprisa 002 Acute Infection Study

    Open Access•Andrew Tomita, Nigel Garrett et al.•ARTICLE•AIDS and Behavior•2014

  • Assessing Adherence in the Caprisa 004 Tenofovir Gel HIV Prevention Trial

    Open Access•Kathleen M Macqueen, Mark A Weaver et al.•ARTICLE•AIDS and Behavior•2014

    Adherence undeniably impacts product effectiveness in microbicide trials, but the connection has proven challenging to quantify using routinely collected behavioral data. We explored this relationship using a nested case-control study in the CAPRISA 004 Tenofovir (TFV) gel HIV prevention trial. Detailed 3-month recall data on sex events, condom and gel use were collected from 72 incident cases and 205 uninfected controls. We then assessed how the…

  • Individualised Motivational Counselling to Enhance Adherence to Antiretroviral Therapy is not Superior to Didactic Counselling in South African Patients

    Open Access•Francois van Loggerenberg, Anne D Grant et al.•ARTICLE•AIDS and Behavior•2014

  • Health-Related Quality of Life Dynamics of HIV-positive South African Women up to ART Initiation

    Open Access•Andrew Tomita, Nigel Garrett et al.•ARTICLE•AIDS and Behavior•2013

  • HIV Transmission Risk Behavior Among HIV-Positive Patients Receiving Antiretroviral Therapy in KwaZulu-Natal, South Africa

    Open Access•Paul A Shuper, Susan M Kiene et al.•ARTICLE•AIDS and Behavior•2013

Sin obras prominentes en esta página.

  • Health-Related Quality of Life Dynamics of HIV-positive South African Women up to ART Initiation

    Open Access•Andrew Tomita, Nigel Garrett et al.•ARTICLE•AIDS and Behavior•2013

  • HIV Transmission Risk Behavior Among HIV-Positive Patients Receiving Antiretroviral Therapy in KwaZulu-Natal, South Africa

    Open Access•Paul A Shuper, Susan M Kiene et al.•ARTICLE•AIDS and Behavior•2013

  • Trial participation disclosure and gel use behavior in the Caprisa 004 tenofovir gel trial

    Stacey Succop, Stacey M Succop et al.•ARTICLE•AIDS Care•2014

    Disclosure, or open communication, by female microbicide trial participants of their trial participation and use of an investigational HIV prevention drug to a sexual partner may affect participants' trial product usage behavior and contribute to poor adherence. With mixed results from recent microbicide clinical trials being linked to differing participant adherence, insights into the communication dynamics between trial participants and their s…

  • Impact of Antiretroviral Therapy on Health-Related Quality of Life among South African Women in the Caprisa 002 Acute Infection Study

    Open Access•Andrew Tomita, Nigel Garrett et al.•ARTICLE•AIDS and Behavior•2014

  • Assessing Adherence in the Caprisa 004 Tenofovir Gel HIV Prevention Trial

    Open Access•Kathleen M Macqueen, Mark A Weaver et al.•ARTICLE•AIDS and Behavior•2014

    Adherence undeniably impacts product effectiveness in microbicide trials, but the connection has proven challenging to quantify using routinely collected behavioral data. We explored this relationship using a nested case-control study in the CAPRISA 004 Tenofovir (TFV) gel HIV prevention trial. Detailed 3-month recall data on sex events, condom and gel use were collected from 72 incident cases and 205 uninfected controls. We then assessed how the…

  • Individualised Motivational Counselling to Enhance Adherence to Antiretroviral Therapy is not Superior to Didactic Counselling in South African Patients

    Open Access•Francois van Loggerenberg, Anne D Grant et al.•ARTICLE•AIDS and Behavior•2014

  • Risk Factors for HIV Acquisition in High Risk Women in a Generalised Epidemic Setting

    Open Access•Nivashnee Naicker, Ayesha B M Kharsany et al.•ARTICLE•AIDS and Behavior•2015

HIV/AIDS Research and Interventions (7 obras) · Medicine (7 obras) · Health psychology (6 obras) · Human immunodeficiency virus (HIV (6 obras) · Internal Medicine (6 obras) · Public health (6 obras) · Adolescent Sexual and Reproductive Health (5 obras) · Clinical Psychology (5 obras) · Clinical Psychology (4 obras) · Family medicine (4 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae